Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 9C75Y | — |
a nurse called to report that an 11-year-old male patient received a SHINGRIX shot instead of MENVEO; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 11-year-old male patient who received Herpes zoster (Shingrix) (batch number 9C75Y, expiry date 02-MAY-2027) for prophylaxis. Co-suspect products included Men ACWY-CRM NVS (Menveo) for prophylaxis. Additional patient notes included Patient is not immunocompromised. On 24-SEP-2025, the patient received the 1st dose of Shingrix. The patient did not receive Menveo. On 24-SEP-2025, an unknown time after receiving Shingrix, the patient experienced wrong vaccine administered (Verbatim: a nurse called to report that an 11-year-old male patient received a SHINGRIX shot instead of MENVEO). The outcome of the wrong vaccine administered was not applicable. Additional Information: GSK Receipt Date: 25-SEP-2025 A nurse called to report that an 11-year-old male patient received a Shingrix shot instead of Menveo. The vaccine was administered on 24 September 2025, and nurse called to know how to proceed.
Comments: Patient is not immunocompromised